ArticleClinical journal of the American Society of Nephrology : CJASN2025

A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia.

Geoffrey A Block et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.